Calculation of Risk of Colorectal and Endometrial Cancer Among Patients With Lynch Syndrome

Gastroenterology

Volumn 137, Issue 5, 2009, Pages 1621-1627

  Stoffel, Elena ^a,b   Mukherjee, Bhramar ^c   Raymond, Victoria M ^c   Tayob, Nabihah ^c   Kastrinos, Fay ^a   Sparr, Jennifer ^b   Wang, Fei ^c   Bandipalliam, Prathap ^b   Syngal, Sapna ^a,b   Gruber, Stephen B ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENOTYPE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; UNITED STATES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 70350090521     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.07.039     Document Type: Article

References (24)

1. Lynch H.T., and de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 348 (2003) 919-932
2. Lindor N.M., Petersen G.M., Hadley D.W., et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296 (2006) 1507-1517
3. Vasen H.F., Mecklin J.P., Khan P.M., et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34 (1991) 424-425
4. Hampel H., Frankel W., Panescu J., et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352 (2005) 1851-1860
5. Umar A., Boland C.R., Terdiman P., et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
6. Aarnio M., Mecklin J.P., Aaltonen L.A., et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64 (1995) 430-433
7. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81 (1999) 214-218
8. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6 (1997) 105-110
9. Watson P., and Lynch H.T. Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 1 (2001) 57-60
10. Vasen H.F., Wijnen J.T., Menko F.H., et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110 (1996) 1020-1027
11. Quehenberger F., Vasen H.F., and van Houwelingen H.C. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42 (2005) 491-496
12. Jenkins M.A., Baglietto L., Dowty J.G., et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 4 (2006) 489-498
13. Alarcon F., Lasset C., Carayol J., et al. Estimating cancer risk in HNPCC by the GRL method. Eur J Hum Genet 15 (2007) 831-836
14. Lange K., Weeks D., and Boehnke M. Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5 (1988) 471-472
15. Antoniou A., Pharoah P.D., Narod S., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72 (2003) 1117-1130
16. Cannings C., and Thompson E.A. Ascertainment in the sequential sampling of pedigrees. Clin Genet 12 (1977) 208-212
17. Hampel H., Stephens J.A., Pukkala E., et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129 (2005) 415-421
18. Barrow E., Robinson L., Alduaij W., et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 75 (2009) 141-149
19. Kastrinos F., Stoffel E.M., Balmaña J., et al. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev 17 (2008) 2044-2051
20. Goecke T., Schulmann K., Engel C., et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 24 (2006) 4285-4292
21. Chen S., Wang W., Lee S., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 (2006) 1479-1487
22. Murff H.J., Spigel D.R., and Syngal S. Does this patient have a family history of cancer?. An evidence-based analysis of the accuracy of family cancer history. JAMA 292 (2004) 1480-1489
23. Douglas F.S., O'Dair L.C., Robinson M., et al. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet 36 (1999) 309-312
24. Sijmons R.H., Boonstra A.E., Reefhuis J., et al. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet 8 (2000) 181-186